| Project Name | Project Stage | Molecule Type | Molecule Source | Disease Area | Indication |
|---|---|---|---|---|---|
| CDH6 mAb - 01 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Ovarian cancer,Renal cell carcinoma |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Raludotatug deruxtecan | DS-6000a; DS6000a; DS-6000; R-DXd; MK-5909 | Phase 3 Clinical | Daiichi Sankyo Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours | Details |
| QLS-5133 | QLS-5133; QLS5133 | Phase 2 Clinical | Qilu Pharmaceutical Co Ltd | Solid tumours | Details |
| HS-20124 | HS-20124; HS20124 | Phase 1 Clinical | Hansoh BioMedical R&D Company | Solid tumours | Details |
| SIM-0505 | SIM-0505 | Phase 1 Clinical | Hainan Xiansheng Re Ming Pharmaceutical Co Ltd | Solid tumours | Details |
| AMT-707 | AMT-707; CUSP-06 | Phase 1 Clinical | Multitude Therapeutics Inc | Carcinoma, Renal Cell; Cholangiocarcinoma; Ovarian Neoplasms; Solid tumours | Details |
